Latest Breaking News On - எங்களுக்கு கூட்டாட்சியின் தரகு - Page 3 : comparemela.com

16 April 2021 | 15:00pm StockMarketWire.com - AstraZeneca s proposed acquisition of Alexion Pharmaceuticals has been cleared by the US Federal Commission, following the end of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act. The announcement follows competition clearances in Canada, Brazil, Russia and other countries globally. Additional global regulatory clearances are pending, including but not limited to the UK, EU and Japan. Marc Dunoyer, executive director and chief financial officer (CFO), said: These clearances further advance us towards closing our acquisition of Alexion. We remain focused on the next chapter for AstraZeneca and Alexion, building on our combined expertise in immunology and precision medicines and our shared ambition to bring more innovative medicines to patients worldwide. We look forward to working closely with other global authorities as we progress toward this goal.

United kingdomMarc dunoyerAlexion pharmaceuticalsUs federal commissionHart scott rodino antitrust improvementsஒன்றுபட்டது கிஂக்டம்அலெக்சியன் மருந்துகள்எங்களுக்கு கூட்டாட்சியின் தரகுஹார்ட் ஸ்காட் ரோடினோ நம்பிக்கையற்ற மேம்பாடுகள்